Polycystic Kidney Clinical Trial
Official title:
Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Triptolide has been approve effective in animal model.
Randomized ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00491517 -
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety
|
Phase 2 | |
Recruiting |
NCT05286632 -
KidneYou - Innovative Digital Therapy
|
N/A | |
Active, not recruiting |
NCT00771888 -
Open-Label Extension of LOCKCYST Trial
|
Phase 2/Phase 3 | |
No longer available |
NCT03717181 -
Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease
|